DexCom G6 for Type 2 Diabetes Mellitus
Phase-Based Progress Estimates
Effectiveness
Safety
Type 2 Diabetes Mellitus+1 More
DexCom G6 - DeviceEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial will study how well a continuous glucose monitor works in people with type 2 diabetes who need insulin.
Eligible Conditions
- Type 2 Diabetes Mellitus
Treatment Effectiveness
Effectiveness Progress
Other trials for Type 2 Diabetes Mellitus
Study Objectives
3 Primary · 0 Secondary · Reporting Duration: 12 weeks
12 weeks
Change in DTSQc scores
Percent change in TIR 70-180 mg/dl
The proportion of patients with % wear time >70% will be reported.
Trial Safety
Safety Progress
Other trials for Type 2 Diabetes Mellitus
Trial Design
1 Treatment Group
Dexcom CGM
1 of 1
Experimental Treatment
100 Total Participants · 1 Treatment Group
Primary Treatment: DexCom G6 · No Placebo Group · N/A
Dexcom CGM
Device
Experimental Group · 1 Intervention: DexCom G6 · Intervention Types: DeviceTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12 weeks
Who is running the clinical trial?
Kathleen DunganLead Sponsor
5 Previous Clinical Trials
325 Total Patients Enrolled
1 Trials studying Type 2 Diabetes Mellitus
42 Patients Enrolled for Type 2 Diabetes Mellitus
DexCom, Inc.Industry Sponsor
122 Previous Clinical Trials
13,024 Total Patients Enrolled
4 Trials studying Type 2 Diabetes Mellitus
197 Patients Enrolled for Type 2 Diabetes Mellitus
Kathleen Dungan, MDPrincipal InvestigatorOSU Medical Center
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have type 2 diabetes.\n
You have a hemoglobin A1c level of at least 8.0%.
You have a smartphone that is compatible with the Clarity App.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments